Passage Bio, Inc.
NASDAQ:PASG
0.596 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.721 | 3.679 | 1.543 | 0.8 | 0.134 | 0 |
| Gross Profit
| -3.721 | -3.679 | -1.543 | -0.8 | -0.134 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 61.419 | 86.053 | 117.673 | 81.788 | 29.738 | 9.167 |
| General & Administrative Expenses
| 41.58 | 49.341 | 60.056 | 30.114 | 6.951 | 0.928 |
| Selling & Marketing Expenses
| -4.721 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 41.58 | 49.341 | 60.056 | 30.114 | 6.951 | 0.928 |
| Other Expenses
| 5.39 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 108.389 | 135.394 | 177.729 | 111.902 | 36.689 | 10.095 |
| Operating Income
| -108.389 | -138.394 | -185.729 | -112.902 | -37.189 | -13.466 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 6.327 | 2.269 | 0.343 | 0.67 | -8.445 | -2.675 |
| Income Before Tax
| -102.062 | -136.125 | -185.386 | -112.232 | -45.634 | -12.77 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 5.39 | 0.731 | 6.114 | -0.47 | 8.945 | -0.696 |
| Net Income
| -102.062 | -136.856 | -191.5 | -111.762 | -54.579 | -12.77 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.86 | -2.51 | -3.59 | -2.89 | -1.19 | -0.53 |
| EPS Diluted
| -1.86 | -2.51 | -3.59 | -2.89 | -1.19 | -0.53 |
| EBITDA
| -99.278 | -132.394 | -169.729 | -110.902 | -26.914 | -7.42 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |